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Conclusion: The γmean, γmedian and γ1% metrics have 
potential to be used as parameters to predict PTV dose 
deviations and had better correlation than the passing rate. 
However for OAR dose deviations, the γmax showed the 
strongest correlation with DVH deviations. This methodology 
is robust the variability in γ calculation. 
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Purpose or Objective: Aim of this study is the evaluation of 
build-up and superficial doses for a Head&Neck treatment, 
delivered by Helical TomoTherapy (HT). Measurements were 
carried out by two different dosimeters (radiochromic films 
and a synthetic single crystal diamond detector) and 
compared with TPS data. Build-up dose profiles and 
superficial dose points were estimated. The reliability of the 
TPS in these critical regions was assessed, giving an insight 
into a subject on which quite contradictory results are 
reported in the literature. 
 
Material and Methods: A home modified Anderson Rando 
phantom was employed to house the detectors. As shown in 
figure (a), two slices of the phantom neck were removed and 
replaced with a PMMA artificial neck, with a hole inside to 
mimic the trachea. This allowed to measure dose profiles and 
superficial dose points with geometrical and scattering 
conditions similar to the ones taking place when a real 
patient is treated. Gafchromic EBT3 films (Ashland Inc., 
Wayne, NJ) were sandwiched inside the neck in oder to 
measure dose profiles and attached to the neck surface for 
superficial dose point assessment. PTW-Frieburg 
microDiamond (mD) was positioned inside drilled holes at 
different known distances respect to the phantom surface.  
 
 
 
Results: In figure (b) one of the measured dose profiles by 
EBT3 and mD is reported, along the Antero-Posterior 
direction, in the range 0-30 mm (distance from the phantom 
surface). TPS data are also shown, as black dots, with an 
associated error of ± 0.9 mm, half of the lateral dimension of 
the calculation pixel (fine grid). The prescribed dose is 
reached within approximately 4 mm from the phantom 
surface and it does not show any significant variation going 
further inside the neck, in particular at the PMMA/air 
interface, in correspondence of the trachea starting point. 
A 1D threshold criterion of 3%/mm was adopted in order to 
discriminate between high and low gradient zones. Dose 
differences (DD) measured by mD are within 2.5% respect to 
TPS, in the low gradient region, while a maximum distance-
to-agreement (DTA) of 0.9 mm is found for the same device, 
in the high gradient region. EBT3 profile shows a more noisy 
behavior, with a maximum DD of 3.8% in the low gradient 
portion of the profile, while DTA is less than 1 mm in the high 
gradient zone. The superficial dose measurement by EBT3 
film is characterized by a DTA of 0.5 mm and a DD of 5.2%.  
 
Conclusion: Build-up dose profiles measured by the two 
dosimeters show the same behavior and are in agreement 
with TPS data; deviations are well within the reference 
tolerance level. The investigation carried out in this work 
offers the possibility of studying the TPS behavior not only in 
terms of dose difference, as carried out for in vivo 
measurements, but also taking into account a “spatial 
displacement”, to be compared with patient (and/or 
dosimeter) positioning uncertainties. 
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Purpose or Objective: To evaluate experimentally the 
accuracy of the dose calculation algorithm AcurosXB in small-
field highly modulated Volumetric Modulated Arc Therapy 
(VMAT). 
 
Material and Methods: The Octavius 1000SRS detector array 
inserted in the rotational Octavius4D phantom (PTW) was 
used, consisting of 977 liquid-filled ion chambers covering an 
area of 11×11cm2. The detector size (2.3×2.3×0.5mm3) and 
the center-to-center distance of the detectors (2.5mm in the 
inner 5.5×5.5cm2 area) are important parameters for correct 
spatial measurement of complex dose distributions with 
steep dose gradients. Clinical treatment plans (n=28), 
characterized by small treatment volumes, 6 and 10MV 
photon beams, and fraction doses between 2.75-30 Gy, were 
projected on the phantom CT data set and recalculated in 
the Eclipse TPS v11 (Varian Medical Systems) using AcurosXB 
with a calculation grid size of 2.5mm and 1mm (field sizes 
<3x3cm2). All measurements were done on a Varian 
TrueBeamSTx linac. The irradiation technique used was 
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VMAT, but in a few cases also dynamic conformal arc for the 
smallest treatment field sizes. The effect of disabling jaw 
tracking, thereby fixating the collimator jaws at 3x3cm2 and 
applying the MLC to shape the smallest apertures was 
investigated for static fields between 3x3cm2 and 
0.5x0.5cm2, and for 7 stereotactic patients with small brain 
metastases. To evaluate the dosimetric agreement between 
measured and calculated dose, a local gamma evaluation 
criterion of 2%/2mm was used.  
 
Results: Regarding the clinical VMAT plans, the mean and SD 
of the volumetric gamma evaluation scores with 10%, 50%, 
80% and 95% cut-off dose values are (96±6.9)%, (95.2±6.8)%, 
(86.7±14.8)% and (56.3±42.3)% respectively. In figure 1, a 
trend can be observed between relative dose differences and 
the field size area of 28 VMAT treatments going from very 
small to medium sized fields. The deviation between 1000SRS 
readings for static fields 3x3, 2x2, 1x1 and 0.5x0.5cm2 
collimated with MLC and jaws fixed at 3x3cm2 and with 
collimator jaws only is on average respectively, 0.3%, 
0.8%,6.7%, 5.4% (6 MV) and 0.2%,1.3%,11.3%,20.1% (10MV). 
The effect of disabling jaw tracking for 7 stereotactic 
patients with treatment techniques VMAT as well as dynamic 
conformal arc is shown in table 1: the smaller the target, the 
higher the improvement in agreement between measured and 
calculated doses when jaws are fixed at 3x3cm2 .  
 
 
 
 
 
Conclusion: Doses calculated for stereotactic VMAT plans 
show an acceptable agreement against measurements with 
the 1000SRS in the Octavius4D system. Except for very small 
highly modulated VMAT fields, larger discrepancies are 
obtained. Fixating the jaws at 3x3cm2 and using the MLC 
with high positional accuracy to shape the smallest apertures 
in contrast to jaw tracking is currently found to be the 
preferred and most accurate treatment technique. 
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Purpose or Objective: In intraoperative electron radiation 
therapy (IOERT) a high single dose is applied to the tumor 
bed directly after resection of the malignancy. During an 
IOERT clinical application special shielding materials are used 
under the tumor bed in order to reduce the absorbed dose on 
critical organs behind the tumor like rib, heart and lung. Such 
absorbers produce backscattered dose. The objective of the 
present study was to investigate the backscattered dose of 
the absorber shielding plates. This could help us to 
comprehend the effect of the clinical application of such 
absorbers. 
 
Material and Methods: The electron beams generated by a 
dedicated mobile IOERT accelerator NOVAC7 (SIT, 
Vicenza/Italy) were employed. The electron beams with 
different energies of 5 and 9 MeV together with 40 and 50 
mm applicators which are most clinically used were utilised. 
These shielding plates are made up of a special steel alloy 
(AISI 316L). The backscattered dose was measured by 
radiochromic films, Gafchromic EBT3 (Ashland, Wayne/USA). 
All films were irradiated with 5 Gy at 100% isodose level.  
 
 
 
Results: Some important aspects of results are explained 
below. 
40mm applicator: At the first film slice, increasing the energy 
from 5 to 9 MeV resulted to a significantly higher 
backscattered dose. At 5 MeV the backscattered dose was 
0.29 Gy, compared to the dose resulted for the film slice 
without the shielding. The corresponding values were 0.63 Gy 
for 9 MeV. This increase might be because of the increased 
energy of the backscattered electrons at higher energy 
beams (9 MeV) which causes higher dose delivery at the same 
depth, compared to low energy beams (5 MeV). Moving 
toward the surface of the phantom the backscattered dose 
decreased significantly (~11%). This occurs due to decrease of 
energy and fluence of backscattered electrons when they 
move toward the phantom surface. 50mm applicator: At 
larger field size of 50 mm, the backscattered dose increased 
remarkably, compared to the 40 mm applicator. In 
comparison with the dose absorbed to the film slice without 
the shielding, the backscattered dose increased 1.5 and 1.3 
Gy for 5 and 9 MeV, respectively. The reason is that at larger 
field size the energy fluence of scattered electrons might be 
higher than the 40 mm applicator and this led to a higher 
dose delivery at the same depth, compared to 40 mm field 
size.  
 
 
 
